^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Rectal Cancer |
| Regimen: | CAPOX (capecitabine + oxaliplatin) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
12/20/2020
Excerpt:
Rectal cancer: CONTINUUM OF CARE - SYSTEMIC THERAPY FOR ADVANCED OR METASTATIC DISEASE...Patient appropriate for intensive therapy…Initial therapy...CAPEOX ± bevacizumab
Rectal Cancer….Total Neoadjuvant Therapy specified as preferred- FOLFOX or CAPEOX
